Citation
- Authors: Poudyal, D., Cui, X., Le, P. M., Hofseth, A. B., Windust, A., Nagarkatti, M., Nagarkatti, P. S., Schetter, A. J., Harris, C. C., Hofseth, L. J.
- Year: 2013
- Journal: PLoS ONE 8 e75034
- Applications: in vitro / antimiR, siRNA / INTERFERin
- Cell types:
- Name: DLD-1
Description: Human colorectal adenocarcinoma
Known as: DLD1, DLD 1 - Name: HCT 116
Description: Human colon carcinoma cells
Known as: HCT116 - Name: LoVo
Description: Human colorectal adenocarcinoma cells
- Name: DLD-1
Method
0.1-10 nM ( siRNA), 10-50 nM (antimiR)
Abstract
Metastasis of colon cancer cells increases the risk of colon cancer mortality. We have recently shown that American ginseng prevents colon cancer, and a Hexane extract of American Ginseng (HAG) has particularly potent anti-inflammatory and anti-cancer properties. Dysregulated microRNA (miR) expression has been observed in several disease conditions including colon cancer. Using global miR expression profiling, we observed increased miR-29b in colon cancer cells following exposure to HAG. Since miR-29b plays a role in regulating the migration of cancer cells, we hypothesized that HAG induces miR-29b expression to target matrix metalloproteinase-2 (MMP-2) thereby suppressing the migration of colon cancer cells. Results are consistent with this hypothesis. Our study supports the understanding that targeting MMP-2 by miR-29b is a mechanism by which HAG suppresses the migration of colon cancer cells.